Abstract:Peroxiredoxin-I is a protein encoded by the Peroxiredoxin I gene, which highly expressed in many tumor tissues, such as lung cancer, breast cancer, rectal cancer, stomach cancer. Peroxiredoxin-I has a proliferative effect and plays a role in cancer development, recurrence or progression. The mAb 109 antibody can specific binding to Peroxiredoxin-I protein. We recently reported the synthesis Tc-99m-labeled mAb109 for Single-photon emission computed tomography (SPECT) imaging. Those studies have showed that Tc-99m-mAb 109 still preserved its biological functions and specifically binding to the target tumors. The aim of this research was to develop new radionuclide labeled mAb109 antibody for prolonged tumor targeted molecular imaging. In this paper, the precursor compound 2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane1,4,7,10-tetraacetic acid-mAb 109 (DOTA-mAb109) was synthesized for potential radioactive imaging agents. Then, a radioisotope indium-111 (t(1/2)= 67.3 h) was labeling to DOTA-mAb109 for further radio-biological evaluation. The DOTA is chelated to the In-111(3+) center through four nitrogens and four carboxylate oxygens, resulting in an eight-coordinate complex. The labeling efficiency of In-111-DOTA-mAb109 was tested by Radio-TLC/HPLC. The radiolabeling yield was over 96%, the radio chemical purity was over 99% by PD-10 column purification. The in vitro stability tests were presented in 5% Human serum albumin (HSA) for 72 h at 25 degrees C Less than 5% In-111 dissociation was detected by Radio-HPLC. In-111-DOTA-mAb109 shows excellent radiochemical property. Nano-SPECT imaging of pancreatic carcinoma-1 tumor-bearing nude mice revealed that tumor uptake of In-111-DOTA-mAb109 got a gradual accumulation from 24 h, 48 h to 72 h after post-injection of 18.5 MBq radiolabeled antibody. The cardiac area was clearly seen up to 48 h post injection, reflecting a long blood circulation time for In-111-DOTA-mAb109. Uptake in the tumor was clearly visualized by emission computed tomography. These results suggest that the In-111-DOTA-mAb109 molecular probe is a promising tracer for tumor diagnosis.

Radiolabeling Morpholino Oligonucleotide with 111in and Its Biodistribution in Normal Mice

Initial Investigations of 99Mtc-Labeled Morpholinos for Radiopharmaceutical Applications

In Vitro Stability of 188Re-Labeled Morpholino Oligonucleotide and Its Distribution in Mice

Synthesis and Evaluation Of111in-Dota-mab109 Monoclonal Antibody for Potential SPECT Molecular Imaging

Radiolabeling of DNA Bipyramid and Preliminary Biological Evaluation in Mice

Optimal Labeling Conditions of 68Ga-Dota-ingr and Its Biodistribution in Mice

Radiolabeling of MAG3-morpholino Oligomers with 188re at High Labeling Efficiency and Specific Radioactivity for Tumor Pretargeting.

Preparation and Biodistribution of ~(99M)tc-Pdgfr-β AODN

[The Radiolabeling Property of Oligonucleotide with 99mtc Using NHS-MAG3 As a Chelator].

^188 Re Labeled MPEG-modified Superparamagnetic Nanogels：preparation and Preliminary Application in Mice

Synthesis, Radiolabeling And Biodistribution Studies Of [Tc-99m(Co)(3)(Mn-Tz-Bpa)](+) In Tumor-Bearing Mice

The Labeling of [Tyr~3]-Octreotide with ~(125)I and Its Biodistribution and Pharmacokinetic

Cytosine Residues Influence Kidney Accumulations of 99Mtc-Labeled Morpholino Oligomers

Synthesis and evaluation of 111 In-labeled d -glucose as a potential SPECT imaging agent

Preparation of 68Ga-Dota-cngr and Its Application in Imaging of the Nude Mice Bearing Human Lung Cancer

A Novel Tetrapeptide for Chelator-Free Radiolabeling in Optimized Preparation of 99Mtc-Radiolabeled Oligonucleotides.

Labeling Monoclonal-Antibodies with Yttrium-90-Dota and Indium-111-Dota Chelates - A Simple and Efficient Method

EXPERIMENTAL STUDY OF RADIOIMMUNOIMAGING WITH~(99m)Tc LABELING F(ab’)2 FRAGMENT

~(125)I/~(111)in Labeled Anti-EGFR Monoclonal Antibody Panitumumab:Preparation and Biodistribution Evaluation in Normal Mice

Labeling of Annexin V With ~(125)I and Its Biodistribution in Mice

Radiolabeling and Biological Evaluation of Novel 99Mtc-Nitrido and 99Mtc-Oxo Complexes with 4-Methoxy-l-phenylalanine Dithiocarbamate for Tumor Imaging.